{
  "basic_data": [
    {
      "hpscreg_name": "HPIi009-A",
      "cell_line_alt_name": "Ryr1-i3372-RIP (HPIi009-A)",
      "cell_type": "hiPSC",
      "frozen": "True"
    }
  ],
  "generator": [
    {
      "group": "Harry Perkins Institute of Medical Research"
    }
  ],
  "contact": [
    {
      "group": "Harry Perkins Institute of Medical Research",
      "first_name": "Joshua",
      "last_name": "Clayton",
      "name_initials": "S",
      "e_mail": "joshua.clayton@perkins.org.au",
      "phone_number": "Missing"
    }
  ],
  "publications": [
    {
      "doi": "10.1016/j.scr.2024.103411",
      "journal": "Stem Cell Research",
      "title": "Generation of two iPSC lines from adult central core disease patients with dominant missense variants in the RYR1 gene",
      "first_author": "Joshua S. Clayton",
      "last_author": "Rhonda L. Taylor",
      "year": "2024",
      "pmid": "38420047"
    }
  ],
  "donor": [
    {
      "age": "A25_29",
      "sex": "Male",
      "disease_name": "Central core disease of muscle; CCD",
      "disease_description": "CCD is a congenital myopathy typically diagnosed by the presence of central-typed cores in type I myofibres. Common clinical features include muscle weakness and hypotonia presenting during infancy, delayed motor development, and joint contractures."
    }
  ],
  "genomic_modifications": [
    {
      "mutation_type": "Variant",
      "cytoband": "19q13.2",
      "delivery_method": "Missing",
      "description": "Heterozygous for RYR1 c.4036C>A (p.Asn1346Lys) variant",
      "genotype": "Heterozygous for RYR1 c.4036C>A (p.Asn1346Lys)",
      "loci_name": "RYR1"
    }
  ],
  "differentiation_results": [
    {
      "cell_type": "Ectoderm",
      "show_potency": "True",
      "marker_list": "OTX2; PAX6",
      "method_used": "RT-qPCR; Immunofluorescence",
      "description": "In vitro directed differentiation"
    },
    {
      "cell_type": "Mesoderm",
      "show_potency": "True",
      "marker_list": "TBXT; BMP4",
      "method_used": "RT-qPCR; Immunofluorescence",
      "description": "In vitro directed differentiation"
    },
    {
      "cell_type": "Endoderm",
      "show_potency": "True",
      "marker_list": "SOX17; GATA4",
      "method_used": "RT-qPCR; Immunofluorescence",
      "description": "In vitro directed differentiation"
    }
  ],
  "undifferentiated_characterisation": [
    {
      "epi_pluri_score": "Missing",
      "pluri_test_score": "Missing",
      "pluri_novelty_score": "Missing"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "14",
      "karyotype": "46,XY",
      "karyotype_method": "G-banding",
      "summary": "Normal karyotype by G-banding at passage 14; 15 metaphase counted, 5 analyzed for each line."
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_type_term": "lymphoblastoid cell line (LCL)",
      "i_source_cell_origin_term": "blood",
      "derivation_year": "2022",
      "non_int_vector": "Sendai virus",
      "non_int_vector_name": "CytoTune-iPS 2.0 Sendai reprogramming kit"
    }
  ],
  "embryonic_derivation": [
    {
      "embryo_stage": "Missing",
      "zp_removal_technique": "Missing",
      "trophectoderm_morphology": "Missing",
      "icm_morphology": "Missing",
      "e_preimplant_genetic_diagnosis": "Missing"
    }
  ],
  "ethics": [
    {
      "ethics_number": "RA/4/20/1008",
      "approval_date": "Missing",
      "institutional_HREC": "University of Western Australia\u2019s Human Research Ethics Committee"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "0.21",
      "passage_method": "Enzymatically"
    }
  ]
}